I'm Chief Business Correspondent for U.S.News and a regular commentator on networks like MSNBC, CNN, Fox Business and NPR. Since I'm a journalist, not an investor, the positions I take are rhetorical, not financial. My job is to make the connections between the abstruse workings of the global economy and the things consumers care about. Oh - and point out the many myths and follies of our hyperbolic media. Busy times for that.
Pure Growth Capital is a boutique financial & corporate communications firm singularly focused on assisting our clients in growing and protecting their shareholders. We focus on niche growth companies and the emerging markets.
Brian Marckx, CFA is the Senior Medical Device / Diagnostics Analyst with Zacks Investment Research. I cover small and micro-cap medical device and diagnostic companies. Focus is development-stage companies with novel and emerging technologies as well as already established names still flying under the radar.
Prior to joining Zacks, Brian worked as a high-yield bond analyst on Wachovia Securities’ institutional trading desks where he specialized in the healthcare and industrials industries. Prior to that he was an analyst in corporate finance at First Union National Bank. Brian has covered the medical device, pharmaceutical and biotechnology industries since joining Zacks.
Brian has been quoted in numerous publications including The Wall Street Journal, Barron's, Bloomberg-Businessweek and Kiplinger. His work has also been cited in various market studies and working papers including those from Massachusetts Institute of Technology, Deloitte & Touche, and Pharmaceutical Manufacturing. Brian graduated with a B.S. in Finance from St. John Fisher College and received his MBA from Wake Forest University. Brian is also a Chartered Financial Analyst charterholder.
Evaluation of the dominant assumptions and an understanding of the dynamics of the economic engine is the basis of an approach to asset allocation that provides for both a rational determination of value and an understanding of sentiment in the form of price as a measure of the irrational nature of the operational environment, an approach that is intended at once to avoid unnecessary risk while at the same time enable gradual rebalance of assets as a means to increase net worth via optimization of appreciation and long term yields. Let's call that buy low and fly high just for fun.
30 years investing and 20 years managing my own business in the retail market
Never say never, But always will lose your ass......so stay flexible....
there is always another winner out there.....you are never holding the only one.....what goes up will come down.
Current role as in-house M&A in information services space, i.e. information, data, analytics, ad tech, digital marketing, etc. Previous roles as private equity analyst and strategy consultant in financial services sector. Actually have to build valuation models, conduct market research and comps analysis for a living.
Disclosure: I am not a financial advisor/adviser. The views expressed here are mine alone and not those of my employer.